Top Markets
#1 ADO Protocol ADO Protocol +336.48%
#2 GoPlus Security GoPlus Security +50.52%
#3 Starpower Starpower +36.17%
#4 Fake World Assets Fake World Assets +29.96%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.56%
#6 GAIB AID GAIB AID +24.67%
#7 Nockchain Nockchain +22.31%
#8 The Black Bull The Black Bull +18.45%
#9 OpenEden OpenEden +14.53%
#10 Tutorial Tutorial +12.76%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
Clasificación en acciones #32966
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
Precio por acción
$0.5351
Capitalización bursátil
$8.15M
Cambio (1 día)
-6.29%
Cambio (1 año)
-64.56%
País
US
Comercio Traws Pharma, Inc. (TRAW)

Categoría

Healthcare
Historial del precio de la acción de Traws Pharma, Inc. (TRAW)
Precio más alto de cierre: $0.55 el 2026-08-01

Precio más bajo de cierre: $1.18M el 2013-07-01
Historial del precio de la acción de Traws Pharma, Inc. desde 2013 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.32 30.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $988.91 51.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.15%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE